Merck Combination Treatment for Lung Cancer Fails Late-stage Study Merck Combination Treatment for Lung Cancer Fails Late-stage Study

Merck said on Thursday a combination of two of its cancer drugs failed to meet the main goals of a late-stage study evaluating it as an initial treatment for a type of lung...Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology Source Type: news